Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 2016

View Archived Issues

Janssen, BMS enter immuno-oncology collaboration in lung cancer

First pivotal trial of intravenous meloxicam achieves primary endpoint

Eisai doses first patient in phase Ib/II study of Halaven plus Halozyme's PEGPH20

Sysmex, Healios and Sumitomo Dainippon partner to develop pre-transplant immune reaction testing

Hisamitsu reports results from phase III study of HP-3060 transdermal system for allergic rhinitis

Pneumococcal vaccination using novel hybrid biological-biomaterial vector

X-Chem and AbbVie form oncology and immunology drug target collaboration

First-in-human trial investigates AGuIX gadolinium-based nanoparticles in brain metastases

Burnet Institute and ARTES Biotechnology to jointly develop HCV vaccine

Neurovance's phase II study of centanafadine in adult ADHD meets endpoints

Beijing Scitech-Mq Pharmaceuticals patents HER1 inhibitors

Phase I study of FluGen's universal influenza vaccine begins

EMA grants PRIME designation to DNX-2401 for recurrent glioblastoma

DPP Zika IgM/IgG assay obtains CE mark for rapid point-of-care detection of Zika virus

Shanghai Institute Materia Medica discloses glucokinase activators

HHS and Yale University develop c-Myc inhibitors

First phase I data for PF-06648671

FDA approves Adlyxin for type 2 diabetes

FTC clears Teva's acquisition of Actavis Generics

Kite Pharma enters license agreement with NIH for fully human anti-CD19 CAR-based product candidate

Pfizer wins auction bid for substantially all of BIND Therapeutics' assets

FDA accepts for review BioMarin's BLA for cerliponase alfa for CLN2 disease

First clinical data for 5-HT-4 receptor partial agonist SUVN-D4010

Cytokinetics and Astellas expand collaboration in skeletal muscle activators

Preclinical profile of novel dual inhibitors of Abeta and tau oligomerization

GSK licenses CNTO-7160 for severe asthma from Janssen

AstraZeneca and Moderna Therapeutics apply to start clinical study of AZD-860 in Germany

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...